Current Positions & Functions

• 2023 – present: Associate Editor (ageing biology section), European Geriatrics Medecine Journal, EU
• 2022 – present: Member of the Academic Board of EuGMS, EU
• 2022 – present: Director of “tempoforme” dependency prevention program, Lille Universty Hospital
• 2022 – present: Team Leader, Glycation from inflammation to ageing, U1167, INSERM, Lille University & Inst.Pasteur Lille
• 2020 – present: Leader of the Specific Interest Group (SIG) on Ageing Biology at EuGMS, EU
• 2019-present: Administrative council member IFRO (Institut des Rencontres de la Forme), Lille
• 2019-present: Scientific Comity member of SFGG (Société Française de Gériatrie & Gérontologie), Paris
• 2009-present: Professor of Geriatrics and Aging Biology, Lille University Hospital, France

GRANTS

• 2023-2025: EJPRD JTC2022. 250 k€
• 2022-2023: START-AIRR NIRAGE. 120 k€
• 2020-2021: CPER DESTRESS-FLU. 90 k€
• 2019-2022: ANR ExoAgeing. Ageing induced by dietary AGEs. 251k€
• 2019-2023: Interreg NWE REGENERTIS. 223k€
• 2018-2020: CPER RAGING. 50 k€
• 2018-2019: CPER: RAGE antagonists fighting InflammAgeing. RAGING 2018. 50k€
• 2017-2022: Interreg NWE RIVER. 640 k€
• 2016-2019: DigestScience Foundation. RAGE implication in renal ageing. 250 K€
• 2015-2018: Industrial funds. VF BioScience. Anti-glycation effect of a probiotic. 180 K€
• 2010-2013: Nord Pas de Calais Region & EU: Glycachic. Chicoree and neoformed products. 244 K€
• 2009-2011: Nord Pas de Calais Region: Food Glycation & vascular Dysfunction in food. 50K€
• 2004: Post-doctoral grant of ALFEDIAM (French Association for Diabetes and metabolic diseases), 30k€
• 2003: Price of the French Society of Nephrology; 2,5 k€

Research background and project

I am a professor of Geriatrics and Ageing Biology at the School of Health and Sport, Lille University, France. My action on health is multidimensional, ranging from health training and education for the identification of reversible fragilities to promoting active ageing driving to successful ageing. I am heading the “glycation, from inflammation to ageing” research team accredited by the Lille University, the University Hospital of Lille, and the Institut Pasteur de Lille, as well as by INSERM at a national level. My research team brings together fundamentalist researchers, teacher-researchers, clinicians, and students of course. Our research activity is focused on the development of drugs (RAGE Receptor antagonists, small molecules) which is strongly implicated in premature ageing during chronic diseases and inflammageing.

I have been elected as Vice Dean in charge of research in our new (2021) Lille School of Health and Sport merging Medicine, Pharmacy, Odontology, Health Engineering and Sport.

With Lynne Cox (Oxford University, UK) we are co-leading the EuGMS Special Interest Group (SIG) on Ageing Biology.
In 2022, I joined the Academic Board of EuGMS (European Geriatrics Medicine Society). Since 2023, I am the Associate Editor of the European Geriatrics Medicine Journal to manage the Biology of Ageing section.

Book (2021)

Je décide de vieillir bien, longtemps en bonne santé. November 2021. Odile Jacob Editions, Paris, France PhD students and Post-docs (2013-2018)

Thesis Supervisor

• 2019-present: Aurélie Mailliez, Directed by Eric BOULANGER & Ivan BAUTMANS (VUB Brussels, Belgium)
• 2015-2019: Julie HAYBRARD (PhD), Directed by Eric BOULANGER & Pascal ODOU (EA7365, GRITA, Lille)
• 2016-2019: Thibault TESSIER (PhD) Directed by Eric BOULANGER & Christelle CAUFFIER (EA4483, Impact of chemical environment on health, Lille)
• 2016-2019: Rachel LITKE (PhD), Directed by Eric BOULANGER & Charles MOOB (Mount Sinai School of Medicine, NYC, NY, USA)
• 2015-2018 : Olivia MAY (PhD), Directed by Eric BOULANGER / Marie FRIMAT & Lubka ROUMENINA (UMR1138 Centre de Recherche des Cordeliers, Paris)
• 2012-2015: Cyril SELLIER (PhD), Directed by Eric BOULANGER
• 2010-2013: Rodrigo LORENZI (PhD), Directed by Eric BOULANGER
• 2009-2015: Nicolas GROSSIN (Post-Doc), Directed by Eric BOULANGER